The Critical Role of Epithelial-Derived Act1 in IL-17- and IL-25-Mediated Pulmonary Inflammation

Overview of attention for article published in The Journal of Immunology, February 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent: 5 patents

f1000: 1 research highlight platform

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

SBE aptamers for treating IL-17a related diseases and conditions

Grant US-11352630-B2

United States of America

07 Jun 2022

Flavonoid IL-17A inhibitors

Grant US-10385034-B2

United States of America

20 Aug 2019

SBE APTAMERS FOR TREATING IL-17a RELATED DISEASES AND CONDITIONS

Application WO-2019018652-A1

World Intellectual Property Organisation (WIPO)

24 Jan 2019

Treatment of IL-17 mediated disease by blocking SEFIR-SEFIR interactions

Grant US-9611295-B2

United States of America

04 Apr 2017

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.